$CALC
CalciMedica, Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020053539 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.060M
YoY Change
% of Gross Profit
Research & Development $4.757M $8.403M
YoY Change -43.39%
% of Gross Profit
Depreciation & Amortization $90.00K $140.0K
YoY Change
% of Gross Profit
Operating Expenses $6.821M $10.37M
YoY Change -34.19%
Operating Profit -$6.821M -$10.37M
YoY Change -34.19%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.100M
YoY Change
Pretax Income -$4.720M
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.716M -$10.21M -$10.26M
YoY Change -53.79%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$225.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.00M
YoY Change
Cash & Equivalents $94.97M $26.98M
Short-Term Investments $0.00
Other Short-Term Assets $100.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $95.11M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.788M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.500M
YoY Change
Total Long-Term Assets $3.279M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $95.11M
Total Long-Term Assets $3.279M
Total Assets $98.39M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.562M
YoY Change
Accrued Expenses $1.023M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.741M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.741M
Total Long-Term Liabilities $0.00
Total Liabilities $7.751M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$124.2M
YoY Change
Common Stock $214.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $90.63M -$92.87M -$83.04M
YoY Change
Total Liabilities & Shareholders Equity $98.39M
YoY Change

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.716M -$10.21M -$10.26M
YoY Change -53.79%
Depreciation, Depletion And Amortization $90.00K $140.0K
YoY Change
Cash From Operating Activities -$5.360M -$10.66M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$50.00K -$340.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$50.00K -$340.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 82.83M 10.00K
YoY Change
NET CHANGE
Cash From Operating Activities -5.360M -10.66M
Cash From Investing Activities -50.00K -340.0K
Cash From Financing Activities 82.83M 10.00K
Net Change In Cash 77.42M -10.99M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$5.360M -$10.66M
Capital Expenditures -$50.00K -$340.0K
Free Cash Flow -$5.310M -$10.32M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
2414000
us-gaap Operating Expenses
OperatingExpenses
20657000
us-gaap Operating Expenses
OperatingExpenses
26974000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6821000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10365000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4716000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-10205000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31396000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-24.10
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1302687
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-116157000
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1001000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
548000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
138000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
95106000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1788000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
1491000
CY2020Q3 us-gaap Assets
Assets
98385000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4562000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1023000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2156000
CY2019Q4 gray Preferred Stock Tranche Obligation
PreferredStockTrancheObligation
2158000
CY2020Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
10000
CY2020Q3 us-gaap Liabilities
Liabilities
7751000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
131363000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
214847000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2879000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3124000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7741000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22570000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5183000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
6821000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40660000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4757000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8403000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15474000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2064000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1962000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4404000
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2396000
CY2019Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2048000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
7189000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
4633000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4716000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10198000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124215000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105836000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
90634000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102954000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98385000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7112000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12253000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18382000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26756000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
226000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7794000
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-110514000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25568000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.52
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-13.74
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2818349
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1317497
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1861229
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
10365000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20657000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26974000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
160000
us-gaap Investment Income Interest
InvestmentIncomeInterest
120000
us-gaap Investment Income Interest
InvestmentIncomeInterest
211000
CY2020Q3 gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
2102000
gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
2158000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5869000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
561000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-72922000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
142000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-10263000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-83043000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
122000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
250000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-92869000
us-gaap Profit Loss
ProfitLoss
-18379000
us-gaap Profit Loss
ProfitLoss
-26763000
us-gaap Share Based Compensation
ShareBasedCompensation
1001000
us-gaap Share Based Compensation
ShareBasedCompensation
548000
us-gaap Depreciation
Depreciation
284000
CY2020Q1 gray Tax Cuts And Jobs Act Of Two Thousand Seventeen Percentage Of Income Limitation On Use Of Net Operating Losses
TaxCutsAndJobsActOfTwoThousandSeventeenPercentageOfIncomeLimitationOnUseOfNetOperatingLosses
0.80
CY2020Q1 gray Income Taxes Receivable Net Operating Loss Term Cares Act
IncomeTaxesReceivableNetOperatingLossTermCARESAct
P5Y
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
83700000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
54787000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
131000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2289000
us-gaap Depreciation
Depreciation
219000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
17000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
25000
gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-227000
gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-1505000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1204000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2581000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1310000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-747000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
613000
gray Increase Decrease In Deferred Liabilities Non Current
IncreaseDecreaseInDeferredLiabilitiesNonCurrent
10000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22293000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21342000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
197000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
457000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18969000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
20100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19903000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19426000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81488000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54918000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79098000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14150000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15870000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12834000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94968000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26984000
gray Deferred Offering Costs Included In Accounts Payable And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
1837000
gray Deferred Offering Costs Included In Accounts Payable And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
13000
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
131363000
gray Property And Equipment Purchases Included In Accounts Payable
PropertyAndEquipmentPurchasesIncludedInAccountsPayable
60000
gray Property And Equipment Purchases Included In Accounts Payable
PropertyAndEquipmentPurchasesIncludedInAccountsPayable
6000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
660000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
405000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
205000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1466000
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
142150096
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
117809883
CY2019Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
148592000
CY2019Q4 gray Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
894000
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
29000
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
58000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1562000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2044000
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.111039552
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On September 18, 2020, the Company effected a 9.0058:1 reverse stock split of its issued and outstanding common stock. Upon the effectiveness of the reverse stock split, (i) all shares of outstanding common stock were adjusted; (ii) the conversion prices of the convertible preferred stock were adjusted; (iii) the number of shares of common stock for which each outstanding option and warrant to purchase common stock is exercisable were adjusted; and (iv) the exercise price of each outstanding option and warrant to purchase common stock was adjusted. All of the outstanding common stock share numbers (including shares of common stock subject to the Company’s options, warrants and as converted for the outstanding convertible preferred stock), share prices, exercise prices and per share amounts contained in the condensed financial statements have been retroactively adjusted in the condensed financial statements to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of common stock were not adjusted as a result of the reverse stock split.
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
79500000
gray Income Taxes Receivable Net Operating Loss Cares Act Relief Description
IncomeTaxesReceivableNetOperatingLossCARESActReliefDescription
In March 2020, the Families First Coronavirus Response Act, or FFCR Act, and the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, were signed into law in response to the COVID-19 pandemic. The FFCR Act and CARES Act include provisions related to refundable payroll tax credits, deferment of employer side social security payments, and retroactively and temporarily (for taxable years beginning before January 1, 2021) suspending the application of the 80%-of-income limitation on the use of net operating losses, which was enacted as part of the Tax Cuts and Jobs Act of 2017. The CARES Act also provides that net operating losses arising in any taxable year beginning after December 31, 2017, and before January 1, 2021 are generally eligible to be carried back up to five years. In June 2020, Assembly Bill 85, or A.B. 85, was signed into California law. A.B. 85 provides for a three-year suspension of the use of net operating losses for medium and large businesses and a three-year cap on the use of business incentive tax credits to offset no more than $5.0 million of tax per year. A.B. 85 suspends the use of net operating losses for taxable years 2020, 2021 and 2022 for certain taxpayers with taxable income of $1.0 million or more. The carryover period for any net operating losses that are suspended under this provision will be extended. A.B. 85 also requires that business incentive tax credits including carryovers may not reduce the applicable tax by more than $5.0 million for taxable years 2020, 2021 and 2022.
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
56000
CY2019Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
104000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
94355000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
13359000
CY2019Q4 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
20086000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
33445000
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2158000
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q3 gray Prepaid Clinical And Research Expenses Noncurrent
PrepaidClinicalAndResearchExpensesNoncurrent
1462000
CY2019Q4 gray Prepaid Clinical And Research Expenses Noncurrent
PrepaidClinicalAndResearchExpensesNoncurrent
1462000
CY2020Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
35000
CY2020Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
559000
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1080000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
192000000
us-gaap Operating Lease Expense
OperatingLeaseExpense
544000000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
176000000
us-gaap Operating Lease Expense
OperatingLeaseExpense
520000000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
196000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
561000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
250000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2396000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2048000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7189000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4633000

Files In Submission

Name View Source Status
0001564590-20-053539-index-headers.html Edgar Link pending
0001564590-20-053539-index.html Edgar Link pending
0001564590-20-053539.txt Edgar Link pending
0001564590-20-053539-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gray-10q_20200930.htm Edgar Link pending
gray-20200930.xml Edgar Link completed
gray-20200930.xsd Edgar Link pending
gray-20200930_cal.xml Edgar Link unprocessable
gray-20200930_def.xml Edgar Link unprocessable
gray-20200930_lab.xml Edgar Link unprocessable
gray-20200930_pre.xml Edgar Link unprocessable
gray-ex311_92.htm Edgar Link pending
gray-ex312_91.htm Edgar Link pending
gray-ex31_104.htm Edgar Link pending
gray-ex321_90.htm Edgar Link pending
gray-ex322_89.htm Edgar Link pending
gray-ex32_105.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending